Investor focus shifted toward a shareholder vote on a proposal to expand the company’s incentive share pool by 20 million shares. ・CEO Angelos Stergiou urged investors to support the expansion, reiterating confidence in the Phase 3 Regal trial.

It doesn't matter how many people NASA's Space Launch System rocket eventually lands on the Moon. No matter whether it's 15 percent as estimated, 20, or even 30 percent more powerful than the Saturn V from the Apollo era, it spiritually replaces.

NASA's $4.1 billion Space Launch System moon rocket was hauled out of the iconic Vehicle Assembly Building Tuesday at the Kennedy Space Center in Florida for a 4.2-mile overnight trip to pad 39B, setting the stage for a long-awaited maiden flight to send ...

Commonwealth Equity Services increased its stake by 32%, adding 9,226 shares worth $162,730. ・CEO Angelos Stergiou reaffirmed confidence in the trial, saying his conviction in its commercial potential remains “as steadfast today as it was day 1.

Which was the most powerful AMG in mid-2013? Was it a supersport lightweight two-seater, or maybe a Black Series model? Or perhaps a beast of a V12-driven luxury barge like an S 65? Well, no! Affalterbach's finest engineers released then a vehicle that ...

The SLS is the world’s most powerful rocket and will enable NASA to return humans to the moon. NASA requested $11.2 billion in the fiscal year 2024 president’s budget request to fund the program through fiscal year 2028, in addition to the $11.8 ...

Sellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the best healthcare penny stocks to buy according to hedge funds. On March 19, Chief Executive Officer Angelos Stergiou reiterated that 2026 is poised to be a pivotal year for Sellas Life Sciences Group Inc.